(NYSE: WST) West Pharmaceutical Services's forecast annual revenue growth rate of 4.52% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.63%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.64%.
West Pharmaceutical Services's revenue in 2025 is $2,960,200,000.On average, 5 Wall Street analysts forecast WST's revenue for 2025 to be $217,879,050,935, with the lowest WST revenue forecast at $212,845,682,000, and the highest WST revenue forecast at $219,727,213,003. On average, 5 Wall Street analysts forecast WST's revenue for 2026 to be $231,481,471,976, with the lowest WST revenue forecast at $225,789,000,500, and the highest WST revenue forecast at $236,071,747,975.
In 2027, WST is forecast to generate $248,576,216,071 in revenue, with the lowest revenue forecast at $245,298,895,919 and the highest revenue forecast at $252,545,716,133.